VNRX Volitionrx Ltd

VolitionRX Ltd is a clinical-stage life sciences company. The Company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.

$3.12  -0.08 (-2.50%)
As of 12/03/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/11/2011
Outstanding shares:  53,536,161
Average volume:  145,030
Market cap:   $171,315,715
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    928661107
ISIN:        US9286611077
Valuation   (See tab for details)
PE ratio:   -6.98
PB ratio:   7.78
PS ratio:   0.00
Return on equity:   -112.13%
Net income %:   -28,844.79%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy